Trust, data, governance: How life sciences can balance the opportunities and risks of AI – responsibly - News Summed Up

Trust, data, governance: How life sciences can balance the opportunities and risks of AI – responsibly


KPMG’s Cian Kelliher, consulting partner, explores the importance of trust, data and governance in responsible AI adoption in life sciences – highlighting both the opportunities and the critical guardrails needed to implement AI safely and effectively. Artificial intelligence is rapidly reshaping the life sciences industry, ushering in a new era of discovery, precision and efficiency. A transformative technology with immense promiseAI has already begun revolutionising many aspects of life sciences. In short, AI offers the life sciences sector a unique chance to:Boost innovation;Cut costs;Reduce timelines;And bring therapies to market faster. The road aheadThe message from KPMG is clear: AI is not merely enhancing the life sciences sector it is redefining it.


Source: Irish Examiner February 11, 2026 17:47 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */